These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 232610)

  • 1. Metabolism of 1 alpha, 2 alpha-epoxyhexahydrocannabinol.
    Ohlsson A; Emanuelson I
    Acta Pharm Suec; 1979; 16(6):396-407. PubMed ID: 232610
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of the in vivo liver metabolites of (--)-delta 7-tetrahydrocannabinol produced by the mouse.
    Harvey DJ; Gill EW; Slater M; Paton WD
    Drug Metab Dispos; 1980; 8(6):439-45. PubMed ID: 6109613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse.
    Harvey DJ; Paton WD
    Drug Metab Dispos; 1980; 8(3):178-86. PubMed ID: 6104583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.
    Agurell S; Halldin M; Lindgren JE; Ohlsson A; Widman M; Gillespie H; Hollister L
    Pharmacol Rev; 1986 Mar; 38(1):21-43. PubMed ID: 3012605
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation on the mutagenicity in the Ames test of 1 alpha,2 alpha-epoxyhexahydrocannabinol and its conversion by deactivating enzymes.
    Ohlsson A; Agurell S; Glatt H; Bently P; Oesch F
    Acta Pharm Suec; 1980; 17(4):189-98. PubMed ID: 6258386
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats.
    Narimatsu S; Watanabe K; Matsunaga T; Yamamoto I; Imaoka S; Funae Y; Yoshimura H
    Drug Metab Dispos; 1992; 20(1):79-83. PubMed ID: 1347001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three monohydroxyacid and two dihydroxyacid metabolites of delta 1-tetrahydrocannabinol in mouse liver.
    Harvey DJ; Paton WD
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):585-99. PubMed ID: 1265340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular distribution of 3h-delta8-tetrahydrocannabinol in rat organs after I.V. administration.
    Jakubovic A; McGeer PL
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):197-200. PubMed ID: 4438825
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of SKF-525-A on the metabolism of (minus)-delta9-tetrahydrocannabinol in the rat brain and liver.
    Estevez VS; Englert LF; Ho BT
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):389-92. PubMed ID: 4851722
    [No Abstract]   [Full Text] [Related]  

  • 10. Concentration-dependent metabolism and toxicity of [14C] styrene oxide in the isolated perfused rat liver.
    Van Anda J; Smith BR; Fouts JR; Bend JR
    J Pharmacol Exp Ther; 1979 Oct; 211(1):207-12. PubMed ID: 490319
    [No Abstract]   [Full Text] [Related]  

  • 11. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    Cook CS; Hauswald C; Oppermann JA; Schoenhard GL
    J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of cannabinol in rat and rabbit liver. Syntheses of 2"-, 3"- and 5"-hydroxycannabinol.
    Widman M; Dahmén J; Leander K; Petersson K
    Acta Pharm Suec; 1975; 12(4):385-92. PubMed ID: 1199738
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro and in vivo metabolism of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP).
    Lemberger L; McMahon RE; Archer RA; Matsumoto K; Rowe H
    J Pharmacol Exp Ther; 1973 Oct; 187(1):169-75. PubMed ID: 4746325
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytochrome P-450 isozymes in metabolic activation of delta 9-tetrahydrocannabinol by rat liver microsomes.
    Narimatsu S; Watanabe K; Matsunaga T; Yamamoto I; Imaoka S; Funae Y; Yoshimura H
    Drug Metab Dispos; 1990; 18(6):943-8. PubMed ID: 1981541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol.
    Bornheim LM; Lasker JM; Raucy JL
    Drug Metab Dispos; 1992; 20(2):241-6. PubMed ID: 1352216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers.
    Halldin MM; Widman M; V Bahr C; Lindgren JE; Martin BR
    Drug Metab Dispos; 1982; 10(4):297-301. PubMed ID: 6126323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spectrofluorimetric method of determining epoxide hydrolase].
    Kranauskas AE; Kravchenko LV; Tutel'ian VA
    Vopr Med Khim; 1986; 32(1):37-9. PubMed ID: 3953010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of repeated administration on the metabolism of (-)- 9 -tetrahydrocannabinols in rats.
    Ho BT; Estevez VS; Englert LF
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):215-8. PubMed ID: 4686105
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes.
    Nordqvist M; Thakker DR; Vyas KP; Yagi H; Levin W; Ryan DE; Thomas PE; Conney AH; Jerina DM
    Mol Pharmacol; 1981 Jan; 19(1):168-78. PubMed ID: 7207460
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol.
    Harbison RD; Mantilla-Plata B
    J Pharmacol Exp Ther; 1972 Feb; 180(2):446-53. PubMed ID: 5010682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.